JPH05503629A - 抗ウィルス剤及び免疫原として使用される、非複製組換え製レトロウィルス粒子 - Google Patents

抗ウィルス剤及び免疫原として使用される、非複製組換え製レトロウィルス粒子

Info

Publication number
JPH05503629A
JPH05503629A JP3501082A JP50108291A JPH05503629A JP H05503629 A JPH05503629 A JP H05503629A JP 3501082 A JP3501082 A JP 3501082A JP 50108291 A JP50108291 A JP 50108291A JP H05503629 A JPH05503629 A JP H05503629A
Authority
JP
Japan
Prior art keywords
hiv
recombinant
particles
gene
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3501082A
Other languages
English (en)
Japanese (ja)
Inventor
ハッファー，オマール，ケイ．
フ，シウ―ロク
セニア，アレン，ダブリュー
トラビス，ブルース，エム．
Original Assignee
オンコーゲン　リミテッド　パートナーシップ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オンコーゲン　リミテッド　パートナーシップ filed Critical オンコーゲン　リミテッド　パートナーシップ
Publication of JPH05503629A publication Critical patent/JPH05503629A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP3501082A 1989-11-20 1990-11-20 抗ウィルス剤及び免疫原として使用される、非複製組換え製レトロウィルス粒子 Pending JPH05503629A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43920589A 1989-11-20 1989-11-20
US439,205 1989-11-20

Publications (1)

Publication Number Publication Date
JPH05503629A true JPH05503629A (ja) 1993-06-17

Family

ID=23743729

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3501082A Pending JPH05503629A (ja) 1989-11-20 1990-11-20 抗ウィルス剤及び免疫原として使用される、非複製組換え製レトロウィルス粒子

Country Status (14)

Country Link
EP (1) EP0502105A4 (cg-RX-API-DMAC10.html)
JP (1) JPH05503629A (cg-RX-API-DMAC10.html)
KR (1) KR920703639A (cg-RX-API-DMAC10.html)
AU (1) AU636944B2 (cg-RX-API-DMAC10.html)
CA (1) CA2068713A1 (cg-RX-API-DMAC10.html)
ES (1) ES2052478T1 (cg-RX-API-DMAC10.html)
FI (1) FI922277A0 (cg-RX-API-DMAC10.html)
GR (1) GR930300005T1 (cg-RX-API-DMAC10.html)
HU (1) HUT60506A (cg-RX-API-DMAC10.html)
NO (1) NO921969L (cg-RX-API-DMAC10.html)
OA (1) OA09698A (cg-RX-API-DMAC10.html)
TW (1) TW216446B (cg-RX-API-DMAC10.html)
WO (1) WO1991007425A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA909302B (cg-RX-API-DMAC10.html)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0431128B1 (en) * 1989-06-01 2003-03-26 Applied Biotechnology, Inc. Vector coding for self-assembled, defective, non-self-propagating viral particles
US5861282A (en) * 1989-10-16 1999-01-19 Whitehead Institute For Biomedical Research Non-infectious HIV particles and uses therefor
WO1991019803A1 (en) * 1990-06-19 1991-12-26 Applied Biotechnology, Incorporated Self assembled, defective, nonself-propagating viral particles
DE4124817A1 (de) * 1991-07-26 1993-01-28 Basf Ag Waessrige polymerisatdispersionen
WO1993009238A1 (en) * 1991-11-08 1993-05-13 The Upjohn Company Feline leukemia virus vaccines
WO1993020840A1 (en) * 1992-04-14 1993-10-28 British Bio-Technology Limited Induction of ctl responses
US7001759B1 (en) 1993-01-26 2006-02-21 The Trustees Of The University Of Pennsylvania Compositions and methods for delivery of genetic material
DE69435182D1 (de) * 1993-01-26 2009-02-26 Univ Pennsylvania Zusammensetzung zur Verabreichung genetischen Materials
ES2249760T3 (es) 1993-01-26 2006-04-01 The Trustees Of The University Of Pennsylvania (A Corporation Of Pennsylvania) Composiciones y procedimientos de administracion de materias geneticas.
GB9304239D0 (en) * 1993-03-01 1993-04-21 British Bio Technology Viral particles
US5858838A (en) 1998-02-23 1999-01-12 Taiwan Semiconductor Manufacturing Company, Ltd. Method for increasing DRAM capacitance via use of a roughened surface bottom capacitor plate
US5955342A (en) * 1994-08-15 1999-09-21 Connaught Laboratories Limited Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region
US6291157B1 (en) 1998-02-23 2001-09-18 Connaught Laboratories Limited Antigenically-marked non-infectious retrovirus-like particles
US6080408A (en) 1994-08-22 2000-06-27 Connaught Laboratories Limited Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles
CN1185811A (zh) * 1995-03-31 1998-06-24 H·沃尔夫 依赖于逆转录病毒样颗粒的抗原呈递系统
US6013506A (en) * 1995-06-05 2000-01-11 Wardley; Richard C. Feline leukemia virus vaccines
US6121021A (en) * 1997-12-16 2000-09-19 Connaught Laboratories Limited Constitutive expression of non-infectious HIV-like particles
AU2221600A (en) 1998-12-31 2000-07-31 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
EP1141314A2 (en) 1998-12-31 2001-10-10 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
ATE384795T1 (de) 1998-12-31 2008-02-15 Novartis Vaccines & Diagnostic Modifizierte hiv env polypeptide
US20020106798A1 (en) 2000-03-02 2002-08-08 Robinson Harriet L. DNA expression vectors and methods of use
US8623379B2 (en) 2000-03-02 2014-01-07 Emory University Compositions and methods for generating an immune response
CN100446812C (zh) * 2001-03-08 2008-12-31 美国国有健康与人类服务部 表达修饰的hiv包膜、gag和pol基因的mva
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
ES2606511T3 (es) 2011-04-06 2017-03-24 Biovaxim Limited Composiciones farmacéuticas para prevenir y/o tratar una enfermedad por VIH en seres humanos
MA42502A (fr) 2015-07-21 2018-05-30 Modernatx Inc Vaccins contre une maladie infectieuse
EP3364949A4 (en) 2015-10-22 2019-07-31 ModernaTX, Inc. CANCER VACCINES
WO2018170256A1 (en) 2017-03-15 2018-09-20 Modernatx, Inc. Herpes simplex virus vaccine
WO2018170270A1 (en) 2017-03-15 2018-09-20 Modernatx, Inc. Varicella zoster virus (vzv) vaccine
MA55321A (fr) 2019-03-15 2022-01-19 Modernatx Inc Vaccins à base d'arn contre le vih

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752565A (en) * 1986-04-07 1988-06-21 The United States Of America As Represented By The Department Of Health And Human Services Cell line producing AIDS viral antigens without producing infectious virus particles
JPH02203783A (ja) * 1989-02-02 1990-08-13 Banyu Pharmaceut Co Ltd 抗原性を有する非感染性エイズウイルス産生クローン化ヒトｔ細胞
JP3140757B2 (ja) * 1989-02-06 2001-03-05 デイナ・フアーバー・キヤンサー・インステイテユート パッケージング欠陥ｈｉｖプロウイルス、細胞系及びその使用
GB8923123D0 (en) * 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus
CA2067778A1 (en) * 1989-10-16 1991-04-17 The Whitehead Institute For Biomedical Research Non-infectious hiv-1 particles and uses therefor

Also Published As

Publication number Publication date
NO921969L (no) 1992-06-26
GR930300005T1 (cg-RX-API-DMAC10.html) 1993-04-28
TW216446B (cg-RX-API-DMAC10.html) 1993-11-21
FI922277A7 (fi) 1992-05-19
KR920703639A (ko) 1992-12-18
WO1991007425A1 (en) 1991-05-30
AU6905591A (en) 1991-06-13
HUT60506A (en) 1992-09-28
ES2052478T1 (es) 1994-07-16
CA2068713A1 (en) 1991-05-21
HU9201659D0 (en) 1992-08-28
AU636944B2 (en) 1993-05-13
EP0502105A1 (en) 1992-09-09
FI922277A0 (fi) 1992-05-19
NO921969D0 (no) 1992-05-19
ZA909302B (en) 1991-09-25
EP0502105A4 (en) 1993-02-24
OA09698A (en) 1993-08-30

Similar Documents

Publication Publication Date Title
AU636944B2 (en) Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens
JP3967374B2 (ja) 同調的インビボ遺伝子発現
JP2537570B2 (ja) エイズ及びその他のレトロウイルス病用ワクチンの遺伝子工学による製造
Wagner et al. Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine
US5166050A (en) Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
FR2587720A2 (fr) Vaccin contre le syndrome immunodeficitaire acquis et intermediaires immunogeniques pour la preparation de ce vaccin et pour des dosages immunologiques de depistage de ce syndrome
EP0345242A2 (fr) Expression de protéines gag de rétrovirus dans les cellules eucaryotes
BE1000811A4 (fr) Anticorps monoclonaux, peptides et compositions les contenant, destinees au diagnostic et au traitement des infections par le virus hiv.
US6235881B1 (en) Polypeptides encoded by novel HIV-2 proviruses
JP2743164B2 (ja) Ａｉｄｓの原因ウィルスの糖蛋白質をコードするウィルスベクター及び組換えｄｎａ、該ベクターにより感染された細胞培養物、並びに抗体
WO1991019803A1 (en) Self assembled, defective, nonself-propagating viral particles
US5736378A (en) Molecular cloning and characterization of the feline immunodeficiency virus isolate PPR
IE921875A1 (en) Vaccine and treatment method for human immunodeficiency¹virus
ES2198400T3 (es) Vector que codifica particulas virales no autopropagantes, defectuosas, auto-ensambladas.
IE904161A1 (en) Nonreplicating recombinant-made retroviral particles useful¹as anti-viral agents and as immunogens for prophylaxis and¹therapy against human retroviruses
JP2003535577A (ja) 免疫不全ウイルス用生ウイルスワクチンとしての組換えラブドウイルス
Van der Ryst et al. Study of the immunogenicity of different recombinant Mengo viruses expressing HIV1 and SIV epitopes
FR2600079A1 (fr) Vecteur viral et adn recombinant codant pour la proteine f du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la proteine, proteine obtenue, vaccin et anticorps obtenus
EP0276591B1 (fr) Vaccin constitué par un vecteur viral et ADN recombinant codant notamment pour la protéine p25 du virus agent causal du S.I.D.A.
FR2620030A1 (fr) Vecteur d'expression des proteines du virus hiv-2, un agent causal du sida, culture cellulaire infectee ou transformee par ce vecteur, proteines obtenues, vaccin et anticorps obtenus
JPS6368075A (ja) 後天性免疫不全症候群に関するワクチンおよび免疫検定法
US20050241009A1 (en) Development of a murine model of HIV-1 infection on the basis of construction of EcoHIV, a chimeric, molecular clone of human immunodeficiency virus type 1 and ecotropic moloney murine leukemia virus competent to infect murine cells and mice
US20030124146A1 (en) Recombinant Rhabdoviruses as live-viral vaccines
Aldovini et al. New AIDS vaccine candidates: antigen delivery and design
WO1998022596A1 (en) RECOMBINANT VACCINIA VIRUS, PROCESS FOR PREPARING Gag PROTEIN PARTICLE STRUCTURE USING THE SAME, PARTICLE PREPARED BY SAID PROCESS, AND USE THEREOF